Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $18.5000 (2.78%) ($17.5000 - $19.7000) on Tue. Dec. 5, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 12.03% (three month average) | RSI | 17 | Latest Price | $18.5000(2.78%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -0.7% a day on average for past five trading days. | Weekly Trend | CAPR declines -9.9% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) EWG(8%) EWI(8%) SKYY(8%) XLF(8%) ARKK(7%) | Factors Impacting CAPR price | CAPR will decline at least -6.015% in a week (0% probabilities). GLD(-8%) GDX(-8%) TLT(-7%) SLV(-7%) SIL(-6%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -6.015% (StdDev 12.03%) | Hourly BBV | 0 () | Intraday Trend | 3.9% | | | |
|
1 - 5 Day Possible Target | $-2.44(-113.19%) | Resistance Level | $21.41 | 5 Day Moving Average | $18.88(-2.01%) | 10 Day Moving Average | $19.6(-5.61%) | 20 Day Moving Average | $21.41(-13.59%) | To recent high | -46.4% | To recent low | 90.7% | Market Cap | $364m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |